CSIMarket
 

Canopy Growth Corporation  (NASDAQ: CGC)

Canopy Growth's

Competitiveness




 

CGC Sales vs. its Competitors Q4 2026



Comparing the current results to its competitors, Canopy Growth reported Revenue increase in the 4 quarter 2026 by 604.15 % year on year.
The sales growth was above Canopy Growth's competitors' average revenue growth of 229.92 %, achieved in the same quarter.

List of CGC Competitors





Revenue Growth Comparisons




Net Income Comparison


Canopy Growth Corporation, faster than the decline experienced by the competitors recorded a net loss, as well as most of its competitors.

<<  CGC Stock Performance Comparisons



  

Overall company Market Share Q4 2026

Due to outstanding performance in Overall company, revenue grew by 604.15 % Canopy Growth has increased its market share in this segment.




<<  More on CGC Market Share.
 
*Market share is calculated based on total revenue.





Publicly Traded Peers of Canopy Growth Corporation




Kaya Holdings Inc
Share Performance



0.00%
This Quarter



Kaya Holdings Inc
Profile

Kaya Holdings Inc's business model revolves around operating and franchising legal cannabis retail stores under the Smoke Shop brand. Their focus is on offering a diverse range of cannabis products, accessories, and services to cater to the needs of consumers in states where marijuana is legalized.

More about Kaya Holdings Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ - mill. $ -0.001 mill. $ -11.857 mill.


Intercure Ltd
Share Performance



+426.21%
This Year



Intercure Ltd
Profile

Intercure Ltd is a company that operates in the healthcare sector. Their business model focuses on providing innovative medical solutions and technologies to improve patient outcomes and quality of life. They likely collaborate with healthcare providers, research institutions, and pharmaceutical companies to develop and market their products.

More about Intercure Ltd 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ - mill. $ 270.200 mill. $ -36.784 mill.


Inmed Pharmaceuticals Inc
Share Performance



+23.21%
This Year



Inmed Pharmaceuticals Inc
Profile

Inmed Pharmaceuticals Inc is a biopharmaceutical company that focuses on the development of cannabinoid-based therapies for various diseases. The company's business model revolves around conducting research and development to identify novel drug candidates, conducting pre-clinical and clinical trials to test the safety and efficacy of these candidates, and seeking partnerships or collaborations with other pharmaceutical companies for the further development and commercialization of successful therapies. By leveraging advancements in cannabinoid science, Inmed Pharmaceuticals aims to provide innovative medical treatments for unmet medical needs.

More about Inmed Pharmaceuticals Inc's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 5.587 mill. $ - mill. $ -8.510 mill.


Incannex Healthcare Inc
Share Performance



-72.26%
This Year



Incannex Healthcare Inc
Profile

Incannex Heal is developing drug candidates including IHL-42X, PSX-001, and IHL-675A.

More about Incannex Healthcare Inc's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 40.071 mill. $ - mill. $ -19.279 mill.


Kaival Brands Innovations Group Inc
Share Performance



-12.76%
This Year



Kaival Brands Innovations Group Inc
Profile

Kaival Brands Innovations Group Inc's business model revolves around developing, marketing, and distributing innovative and high-quality vaping products.

More about Kaival Brands Innovations Group Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 0.332 mill. $ 0.375 mill. $ -13.190 mill.

18 more competitors available

Sign in to see all competitors

Sources: Canopy Growth Corporation’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Canopy Growth Corporation versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.